Ramtin Lichtenberger

604 total citations
6 papers, 462 citations indexed

About

Ramtin Lichtenberger is a scholar working on Molecular Biology, Immunology and Dermatology. According to data from OpenAlex, Ramtin Lichtenberger has authored 6 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Immunology and 1 paper in Dermatology. Recurrent topics in Ramtin Lichtenberger's work include S100 Proteins and Annexins (4 papers), Immunotherapy and Immune Responses (2 papers) and melanin and skin pigmentation (1 paper). Ramtin Lichtenberger is often cited by papers focused on S100 Proteins and Annexins (4 papers), Immunotherapy and Immune Responses (2 papers) and melanin and skin pigmentation (1 paper). Ramtin Lichtenberger collaborates with scholars based in Germany, Switzerland and United Kingdom. Ramtin Lichtenberger's co-authors include Christoffer Gebhardt, Jochen Utikal, Tim Holland‐Letz, Maike Reith, Kathrin Tarnanidis, Dirk Schadendorf, Viktor Umansky, Antje Sucker, Alexandra Sevko and Philipp Beckhove and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Ramtin Lichtenberger

6 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ramtin Lichtenberger Germany 5 273 262 132 46 46 6 462
Kathrin Tarnanidis Germany 3 252 0.9× 253 1.0× 109 0.8× 8 0.2× 44 1.0× 4 388
Zsuzsanna Fejôs Hungary 8 479 1.8× 492 1.9× 123 0.9× 21 0.5× 34 0.7× 11 638
Da Qian China 9 73 0.3× 168 0.6× 166 1.3× 4 0.1× 50 1.1× 36 366
Song Lu Hong Kong 7 32 0.1× 97 0.4× 94 0.7× 49 1.1× 75 1.6× 11 355
S. Muthuramalingam United Kingdom 6 190 0.7× 137 0.5× 85 0.6× 12 0.3× 44 1.0× 10 346
Bouchra Ghazi Morocco 6 176 0.6× 175 0.7× 96 0.7× 38 0.8× 22 0.5× 22 361
Ali Hussain United States 5 65 0.2× 40 0.2× 129 1.0× 23 0.5× 55 1.2× 5 278
Giuseppina Vescio Italy 9 91 0.3× 101 0.4× 100 0.8× 21 0.5× 42 0.9× 26 307
Jiadai Xu China 11 83 0.3× 54 0.2× 143 1.1× 33 0.7× 17 0.4× 43 288
Li Zuo China 13 93 0.3× 110 0.4× 252 1.9× 4 0.1× 118 2.6× 35 451

Countries citing papers authored by Ramtin Lichtenberger

Since Specialization
Citations

This map shows the geographic impact of Ramtin Lichtenberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramtin Lichtenberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramtin Lichtenberger more than expected).

Fields of papers citing papers by Ramtin Lichtenberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramtin Lichtenberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramtin Lichtenberger. The network helps show where Ramtin Lichtenberger may publish in the future.

Co-authorship network of co-authors of Ramtin Lichtenberger

This figure shows the co-authorship network connecting the top 25 collaborators of Ramtin Lichtenberger. A scholar is included among the top collaborators of Ramtin Lichtenberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramtin Lichtenberger. Ramtin Lichtenberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Wagner, Nikolaus B., Benjamin Weide, Maike Reith, et al.. (2019). Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies. Journal for ImmunoTherapy of Cancer. 7(1). 343–343. 67 indexed citations
2.
Lichtenberger, Ramtin, Michael A. Simpson, Catherine Smith, Juliet N. Barker, & Alexander A. Navarini. (2017). Genetic architecture of acne vulgaris. Journal of the European Academy of Dermatology and Venereology. 31(12). 1978–1990. 39 indexed citations
3.
Gebhardt, Christoffer, Ramtin Lichtenberger, & Jochen Utikal. (2016). Biomarker value and pitfalls of serum S100B in the follow‐up of high‐risk melanoma patients. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 14(2). 158–164. 35 indexed citations
4.
Gebhardt, Christoffer, Alexandra Sevko, Huanhuan Jiang, et al.. (2015). Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab. Clinical Cancer Research. 21(24). 5453–5459. 290 indexed citations
5.
Wagner, Nikolaus B., Benjamin Weide, Maike Reith, et al.. (2015). Diminished levels of the soluble form of RAGE are related to poor survival in malignant melanoma. International Journal of Cancer. 137(11). 2607–2617. 29 indexed citations
6.
Gebhardt, Christoffer, Nikolaus B. Wagner, Benjamin Weide, et al.. (2014). RAGE ligand S100A8/A9 as a novel prognostic biomarker for high-risk melanoma patients.. Journal of Clinical Oncology. 32(15_suppl). 9070–9070. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026